GPC3/CD3 Bispecific antibody (sinobaybiotech)

N/A

Report date: 2026/04/24 20:01:59

Base Information

Drug NameGPC3/CD3 Bispecific antibody (sinobaybiotech)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Glypican-3CD3 T-cell engagers
TargetsGlypican-3T cell surface glycoprotein CD3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai SinoBay Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai SinoBay Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A